Author

Wangpaichitr M

Associate Professor (Research), University of Miami - Cited by 2,704 - Tumor metabolism - Drug resistance

Biography

Medhi Wangpaichitr Research Associate Professor, Chairman of Biosafety/Chemical Hygiene at the Miami VA Hospital, Florida, USA. His research endeavor focuses on elucidation of the underlying mechanisms of metabolic reprogramming observed in lung cancers that develop acquired resistance to chemotherapy with the overarching goal of identification of potential targets for development of novel anticancer therapy.
Title
Cited by
Year
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma
LG Feun, YY Li, C Wu, M Wangpaichitr, PD Jones, SP Richman, ...Cancer 125 (20), 3603-3614, 2019201
128
2019
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
M Wangpaichitr, C Wu, YY Li, DJM Nguyen, H Kandemir, S Shah, S Chen, ...Oncotarget 8 (30), 49275, 2017201
78
2017
Relationship of metabolic alterations and PD-L1 expression in cisplatin resistant lung cancer
M Wangpaichitr, H Kandemir, YY Li, C Wu, DJM Nguyen, LG Feun, ...Cell & developmental biology 6 (2), 2017201
40
2017
Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is …
Y Long, WB Tsai, JT Chang, M Estecio, M Wangpaichitr, N Savaraj, ...Oncotarget 7 (50), 82658, 2016201
40
2016
Autophagic mechanism in anti-cancer immunity: its pros and cons for cancer therapy
YY Li, LG Feun, A Thongkum, CH Tu, SM Chen, M Wangpaichitr, C Wu, ...International journal of molecular sciences 18 (6), 1297, 2017201
37
2017
Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin
N Savaraj, C Wu, YY Li, M Wangpaichitr, M You, J Bomalaski, W He, ...Oncotarget 6 (8), 6295, 2015201
36
2015
Targeting the kynurenine pathway for the treatment of cisplatin-resistant lung cancer
DJM Nguyen, G Theodoropoulos, YY Li, C Wu, W Sha, LG Feun, ...Molecular cancer research 18 (1), 105-117, 2020202
36
2020
Growth hormone-releasing hormone receptor antagonist modulates lung inflammation and fibrosis due to bleomycin
C Zhang, R Cai, A Lazerson, G Delcroix, M Wangpaichitr, M Mirsaeidi, ...Lung 197, 541-549, 2019201
32
2019
The combination of arginine deprivation and 5-fluorouracil improves therapeutic efficacy in argininosuccinate synthetase negative hepatocellular carcinoma
A Thongkum, C Wu, YY Li, M Wangpaichitr, P Navasumrit, V Parnlob, ...International journal of molecular sciences 18 (6), 1175, 2017201
26
2017
BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma
YY Li, C Wu, SM Chen, SS Shah, M Wangpaichitr, LG Feun, MT Kuo, ...Oncotarget 7 (14), 17665, 161
20
2016
A Kinetic Dearomatization Strategy for an Expedient Biomimetic Route to the Bielschowskysin Skeleton
P Scesa, M Wangpaichitr, N Savaraj, L West, SP RocheAngewandte Chemie 130 (5), 1330-1335, 202
18
2018
Combination of arginine deprivation with TRAIL treatment as a targeted-therapy for mesothelioma
M Wangpaichitr, C Wu, G Bigford, G Theodoropoulos, M You, YY Li, ...Anticancer research 34 (12), 6991-6999, 2014201
17
2014
Degradation of AMPK‐α1 sensitizes BRAF inhibitor‐resistant melanoma cells to arginine deprivation
YY Li, C Wu, SS Shah, SM Chen, M Wangpaichitr, MT Kuo, LG Feun, ...Molecular oncology 11 (12), 1806-1825, 202
17
2017
Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know
S Bhatia, K Pereira, P Mohan, G Narayanan, M Wangpaichitr, N SavarajIndian Journal of Radiology and Imaging 26 (01), 81-91, 2016201
17
2016
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
LG Feun, M Wangpaichitr, YY Li, D Kwon, SP Richman, PJ Hosein, ...Journal of hepatocellular carcinoma, 9-, 2018201
15
2018
Cisplatin resistance and redox-metabolic vulnerability: a second alteration
M Wangpaichitr, G Theodoropoulos, DJM Nguyen, C Wu, SA Spector, ...International journal of molecular sciences 22 (14), 7379, 2021202
13
2021
Growth hormone-releasing hormone in lung physiology and pulmonary disease
C Zhang, T Cui, R Cai, M Wangpaichitr, M Mirsaeidi, AV Schally, ...Cells 9 (10), 2331, 2020202
11
2020
Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin
YH Sitbon, F Diaz, K Kazmierczak, J Liang, M Wangpaichitr, ...Journal of General Physiology 153 (7), e202012801, 2021202
11
2021
Immunotherapy for hepatocellular carcinoma: the force awakens in HCC
LG Feun, YY Li, M Wangpaichitr, CJ Wu, N SavarajHepatoma Research 3 (3), 3, 2017201
4
2017
Kynurenine-Aryl hydrocarbon receptor axis: A crucial modulator of immunometabolism in cisplatin resistant lung cancer
M Wangpaichitr, DJM Nguyen, YY Li, C Wu, LG Feun, N SavarajCancer Research 79 (1_Supplement), 461-461, 2019201
3
2019

Referred From: https://scholar.google.com/citations?user=pVySaHcAAAAJ&hl=en

Cited by
Citations 2704
h-index 26
i10-index 38
Recommended Journals
Open Access Journals